文献速递甲状腺疾病

CD34+眼眶成纤维细胞通过miR-182-5p参与甲状腺眼病发病机制

CD34+ Orbital Fibroblasts Contribute to the Pathogenesis of Thyroid Eye Disease via miR-182-5p.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

病例对照研究取25例甲状腺眼病患者与24名健康供者的眼眶结缔组织和成纤维细胞,发现miR-182-5p在患者组织及CD34+成纤维细胞中高表达;IL-6/STAT3信号激活促进其表达,miR-182-5p通过靶向Smad7促进CD34+成纤维细胞增殖、迁移、纤维化并抑制凋亡,作者认为其可能作为治疗靶点。

要点

  • 甲状腺眼病患者的眼眶结缔组织及CD34+成纤维细胞中miR-182-5p高表达。
  • IL-6/STAT3信号通路激活可促进CD34+成纤维细胞中miR-182-5p的表达。
  • miR-182-5p通过靶向Smad7促进CD34+成纤维细胞增殖、迁移、纤维化并抑制凋亡。

核心结论

  • IL-6/STAT3/miR-182-5p通路导致CD34+眼眶成纤维细胞活化。
  • miR-182-5p通过靶向Smad7促进CD34+眼眶成纤维细胞增殖、迁移、纤维化和抗凋亡。
  • 作者认为miR-182-5p可能作为甲状腺眼病的治疗靶点。

研究设计与样本

  • 病例对照研究,纳入25例甲状腺眼病患者与24名健康供者,获取眼眶结缔组织和眼眶成纤维细胞。
  • 采用miRNA测序检测眼眶结缔组织中miRNA差异表达,并选择miR-182-5p进行后续实验。

主要发现

  • miR-182-5p在甲状腺眼病眼眶结缔组织及其来源的CD34+眼眶成纤维细胞中高表达。
  • 甲状腺眼病眼眶结缔组织中白细胞介素6、白细胞介素17A、CD34及磷酸化STAT3(Ser727和Tyr705)表达增加。
  • miR-182-5p增强CD34+眼眶成纤维细胞的创伤修复能力、增殖和RANTES表达,同时抑制凋亡。
  • 转染miR-182-5p的CD34+眼眶成纤维细胞易发生TGF-β启动的肌成纤维细胞分化。
  • 荧光素酶报告和pull-down实验显示Smad7为miR-182-5p的下游靶点,调控CD34+眼眶成纤维细胞的增殖、迁移、纤维化和凋亡。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: CD34+ orbital fibroblasts (OFs) play a pathogenic role in thyroid eye disease (TED). Several micro (mi)RNAs have been shown to promote TED progression. OBJECTIVE: This study aims to explore the regulatory effects of miRNAs on CD34+ OFs and to find potential therapeutic targets. METHODS: In this case-control study, orbital connective tissues (OCTs) and OFs were obtained from 25 TED patients and 24 healthy donors. MiRNA-seq was performed to examine differential expression of miRNAs in OCTs, and miR-182-5p was selected for subsequent experiments. MiR-182-5p was detected both in CD34+ and CD34- OFs. The upstream regulators of miR-182-5p were studied. Downstream targets of miR-182-5p were analyzed. The functionality of miR-182-5p in CD34+ OFs was evaluated. RESULTS: MiR-182-5p was highly expressed in TED OCTs and their derived CD34+ OFs. TED OCTs displayed increased expression of interleukin (IL)-6, IL-17A, CD34, and phosphorylated STAT3 at Ser727 and Tyr705. Activation of IL-6/STAT3 signaling promoted the expression of miR-182-5p in CD34+ OFs. MiR-182-5p enhanced wound repair ability, proliferation, and RANTES expression while inhibiting apoptosis in CD34+ OFs. CD34+ OFs transfected with miR-182-5p were susceptible to TGF-β-initiated myofibroblast differentiation. Luciferase reporter and pull-down assays revealed Smad7 as the downstream target of miR-182-5p, which modulated the proliferation, migration, fibrosis, and apoptosis of CD34+ OFs. CONCLUSION: The IL-6/STAT3/miR-182-5p pathway led to activation of CD34+ OFs. MiR-182-5p promoted the proliferation, migration, fibrosis, and anti-apoptosis of CD34+ OFs via targeting Smad7. Our findings suggest that miR-182-5p may potentially serve as a therapeutic target for TED.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Yu B, Wang Y, Jin J, et al. CD34+ Orbital Fibroblasts Contribute to the Pathogenesis of Thyroid Eye Disease via miR-182-5p. J Clin Endocrinol Metab. 2025. PMID: 39693241. doi:10.1210/clinem/dgae876

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。